Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Jida Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Wuxi, China, and a key subsidiary of Grand Pharmaceutical Group. Established in 1993, the company focuses on the research, development, and large-scale production of ophthalmic and cardiovascular drugs. It is particularly recognized for its extensive portfolio of ophthalmic preparations, including eye drops and ointments for treating glaucoma, cataracts, and ocular infections. Operating under strict GMP standards, Wuxi Jida serves as a core manufacturing hub for Grand Pharma's ophthalmology business unit. The company's products are well-established in the Chinese market, contributing significantly to the parent group's dominant position in specialized therapeutic segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Jida.